Galanin has tumor suppressor activity and is frequently inactivated by aberrant promoter methylation in head and neck cancer
about
G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?Predictive value of epigenetic alterations in head and neck squamous cell carcinomaGlucose-regulated protein 78 (Grp78) confers chemoresistance to tumor endothelial cells under acidic stressThe G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.Dnmt3a in Sim1 neurons is necessary for normal energy homeostasisAberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinomaAccurate computation of survival statistics in genome-wide studiesDNA Methylation Modulates Nociceptive Sensitization after Incision.A Pyrosequencing Assay for the Quantitative Methylation Analysis of GALR1 in Endometrial Samples: Preliminary Results.Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5.Analysis of Site-Specific Methylation of Tumor-Related Genes in Head and Neck Cancer: Potential Utility as Biomarkers for Prognosis.Epigenetic inactivation of galanin receptors in salivary duct carcinoma of the parotid gland: Potential utility as biomarkers for prognosis.The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: a site-specific analysis.Tumors of the upper aerodigestive tract
P2860
Q26801162-C2F2BD3E-0367-4A61-839A-1739512A7C5FQ27690755-95B65DCE-1459-4A7A-AA2E-D3B8104D72F7Q28540019-6B86838B-B65C-44BE-828E-88A0AC35C963Q33623170-E1C8DCE0-2F11-49AC-A453-D5D76E2E1BCDQ34491670-DBA023F9-473A-454E-A8E5-CB5A7CADACB5Q35143989-A8CB5836-B633-42EF-86DC-4A9FEDF6B197Q35581820-D48E0792-16E8-4EFA-8C68-08C725D9A334Q35831786-A29B49EB-25F9-4D59-BCBB-BE77A4DF3943Q36173002-41BB07DD-16FC-4995-AFED-F7D655EE33C0Q38245688-66A877C6-C359-42AD-8E93-75FB16150398Q39079661-4F429527-0F7B-49ED-8997-25B0F3E20855Q41120997-64F2AFA8-D711-49AA-AF6A-B530F1B0525FQ47113094-7AE6F9BA-2A40-4A37-B3A8-58D2F3EF32D2Q48182545-E320F9E0-D351-4A54-8445-AE95EC4FDD22Q54997136-5B4F3E5D-50DE-4DAB-A214-CC262734A1A8Q55346706-D24C5D62-5B6E-46D0-9878-0C14D0F5005AQ58426138-10A1EEA9-DF18-4613-B92E-1D5163E3E678
P2860
Galanin has tumor suppressor activity and is frequently inactivated by aberrant promoter methylation in head and neck cancer
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Galanin has tumor suppressor a ...... lation in head and neck cancer
@en
type
label
Galanin has tumor suppressor a ...... lation in head and neck cancer
@en
prefLabel
Galanin has tumor suppressor a ...... lation in head and neck cancer
@en
P2093
P2860
P356
P1476
Galanin has tumor suppressor a ...... lation in head and neck cancer
@en
P2093
Andrew Cole
Atsushi Imai
Goro Takahashi
Hiroyuki Mineta
Kiyoshi Misawa
Satoru Takebayashi
Takayuki Uehara
Takeharu Kanazawa
Yuki Misawa
P2860
P304
P356
10.1593/TLO.13115
P577
2013-06-01T00:00:00Z